Selected research
Market Structure
Global Romidepsin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Romidepsin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Romidepsin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Romidepsin include Santa Cruz Biotechnology, Inc., Shanghai Rechem science Co., Ltd., Shanghai lollane biological technology Co.,Ltd., Ningbo Inno Pharmchem Co., Ltd., Merck Group, Dalian Meilun Biotech Co., Ltd., TargetMol Chemicals Inc, Selleck Chemicals and InvivoChem LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Romidepsin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Romidepsin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Romidepsin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Romidepsin market size, projected growth trends, production technologies, key applications, and end-use industries.
Romidepsin Segment by Company
Santa Cruz Biotechnology, Inc.
Shanghai Rechem science Co., Ltd.
Shanghai lollane biological technology Co.,Ltd.
Ningbo Inno Pharmchem Co., Ltd.
Merck Group
Dalian Meilun Biotech Co., Ltd.
TargetMol Chemicals Inc
Selleck Chemicals
InvivoChem LLC
Cckinase, Inc.
Cayman Chemical Company
BPS Bioscience, Inc.
Apexbio Technology LLC
AdooQ BioScience
Romidepsin Segment by Type
0.98
>98%
Romidepsin Segment by Application
Biological
Medical
Romidepsin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Romidepsin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Romidepsin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Romidepsin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Romidepsin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Romidepsin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Romidepsin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Romidepsin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.98
- >98%
Applications
- Biological
- Medical
Companies covered
- Santa Cruz Biotechnology, Inc.
- Shanghai Rechem science Co., Ltd.
- Shanghai lollane biological technology Co.,Ltd.
- Ningbo Inno Pharmchem Co., Ltd.
- Merck Group
- Dalian Meilun Biotech Co., Ltd.
- TargetMol Chemicals Inc
- Selleck Chemicals
- InvivoChem LLC
- Cckinase, Inc.
- Cayman Chemical Company
- BPS Bioscience, Inc.
- Apexbio Technology LLC
- AdooQ BioScience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Romidepsin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Romidepsin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Romidepsin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Romidepsin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Romidepsin Market Dynamics
- 2.1 Romidepsin Industry Trends
- 2.2 Romidepsin Industry Drivers
- 2.3 Romidepsin Industry Opportunities and Challenges
- 2.4 Romidepsin Industry Restraints
3 Romidepsin Market by Manufacturers
- 3.1 Global Romidepsin Revenue by Manufacturers (2021-2026)
- 3.2 Global Romidepsin Sales by Manufacturers (2021-2026)
- 3.3 Global Romidepsin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Romidepsin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Romidepsin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Romidepsin Manufacturers, Product Type & Application
- 3.7 Global Romidepsin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Romidepsin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Romidepsin Players Market Share by Revenue in 2025
- 3.8.3 2025 Romidepsin Tier 1, Tier 2, and Tier 3
4 Romidepsin Market by Type
- 4.1 Romidepsin Type Introduction
- 4.1.1 0.98
- 4.1.2 >98%
- 4.2 Global Romidepsin Sales by Type
- 4.2.1 Global Romidepsin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Romidepsin Sales by Type (2021-2032)
- 4.2.3 Global Romidepsin Sales Market Share by Type (2021-2032)
- 4.3 Global Romidepsin Revenue by Type
- 4.3.1 Global Romidepsin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Romidepsin Revenue by Type (2021-2032)
- 4.3.3 Global Romidepsin Revenue Market Share by Type (2021-2032)
5 Romidepsin Market by Application
- 5.1 Romidepsin Application Introduction
- 5.1.1 Biological
- 5.1.2 Medical
- 5.2 Global Romidepsin Sales by Application
- 5.2.1 Global Romidepsin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Romidepsin Sales by Application (2021-2032)
- 5.2.3 Global Romidepsin Sales Market Share by Application (2021-2032)
- 5.3 Global Romidepsin Revenue by Application
- 5.3.1 Global Romidepsin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Romidepsin Revenue by Application (2021-2032)
- 5.3.3 Global Romidepsin Revenue Market Share by Application (2021-2032)
6 Global Romidepsin Sales by Region
- 6.1 Global Romidepsin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Romidepsin Sales by Region (2021-2032)
- 6.2.1 Global Romidepsin Sales by Region (2021-2026)
- 6.2.2 Global Romidepsin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Romidepsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Romidepsin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Romidepsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Romidepsin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Romidepsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Romidepsin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Romidepsin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Romidepsin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Romidepsin Revenue by Region
- 7.1 Global Romidepsin Revenue by Region
- 7.1.1 Global Romidepsin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Romidepsin Revenue by Region (2021-2026)
- 7.1.3 Global Romidepsin Revenue by Region (2027-2032)
- 7.1.4 Global Romidepsin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Romidepsin Revenue (2021-2032)
- 7.2.2 North America Romidepsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Romidepsin Revenue (2021-2032)
- 7.3.2 Europe Romidepsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Romidepsin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Romidepsin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Romidepsin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Romidepsin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Santa Cruz Biotechnology, Inc.
- 8.1.1 Santa Cruz Biotechnology, Inc. Company Information
- 8.1.2 Santa Cruz Biotechnology, Inc. Business Overview
- 8.1.3 Santa Cruz Biotechnology, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Santa Cruz Biotechnology, Inc. Romidepsin Product Portfolio
- 8.1.5 Santa Cruz Biotechnology, Inc. Recent Developments
- 8.2 Shanghai Rechem science Co., Ltd.
- 8.2.1 Shanghai Rechem science Co., Ltd. Company Information
- 8.2.2 Shanghai Rechem science Co., Ltd. Business Overview
- 8.2.3 Shanghai Rechem science Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shanghai Rechem science Co., Ltd. Romidepsin Product Portfolio
- 8.2.5 Shanghai Rechem science Co., Ltd. Recent Developments
- 8.3 Shanghai lollane biological technology Co.,Ltd.
- 8.3.1 Shanghai lollane biological technology Co.,Ltd. Company Information
- 8.3.2 Shanghai lollane biological technology Co.,Ltd. Business Overview
- 8.3.3 Shanghai lollane biological technology Co.,Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shanghai lollane biological technology Co.,Ltd. Romidepsin Product Portfolio
- 8.3.5 Shanghai lollane biological technology Co.,Ltd. Recent Developments
- 8.4 Ningbo Inno Pharmchem Co., Ltd.
- 8.4.1 Ningbo Inno Pharmchem Co., Ltd. Company Information
- 8.4.2 Ningbo Inno Pharmchem Co., Ltd. Business Overview
- 8.4.3 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Product Portfolio
- 8.4.5 Ningbo Inno Pharmchem Co., Ltd. Recent Developments
- 8.5 Merck Group
- 8.5.1 Merck Group Company Information
- 8.5.2 Merck Group Business Overview
- 8.5.3 Merck Group Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Group Romidepsin Product Portfolio
- 8.5.5 Merck Group Recent Developments
- 8.6 Dalian Meilun Biotech Co., Ltd.
- 8.6.1 Dalian Meilun Biotech Co., Ltd. Company Information
- 8.6.2 Dalian Meilun Biotech Co., Ltd. Business Overview
- 8.6.3 Dalian Meilun Biotech Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Dalian Meilun Biotech Co., Ltd. Romidepsin Product Portfolio
- 8.6.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
- 8.7 TargetMol Chemicals Inc
- 8.7.1 TargetMol Chemicals Inc Company Information
- 8.7.2 TargetMol Chemicals Inc Business Overview
- 8.7.3 TargetMol Chemicals Inc Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 TargetMol Chemicals Inc Romidepsin Product Portfolio
- 8.7.5 TargetMol Chemicals Inc Recent Developments
- 8.8 Selleck Chemicals
- 8.8.1 Selleck Chemicals Company Information
- 8.8.2 Selleck Chemicals Business Overview
- 8.8.3 Selleck Chemicals Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Selleck Chemicals Romidepsin Product Portfolio
- 8.8.5 Selleck Chemicals Recent Developments
- 8.9 InvivoChem LLC
- 8.9.1 InvivoChem LLC Company Information
- 8.9.2 InvivoChem LLC Business Overview
- 8.9.3 InvivoChem LLC Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 InvivoChem LLC Romidepsin Product Portfolio
- 8.9.5 InvivoChem LLC Recent Developments
- 8.10 Cckinase, Inc.
- 8.10.1 Cckinase, Inc. Company Information
- 8.10.2 Cckinase, Inc. Business Overview
- 8.10.3 Cckinase, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Cckinase, Inc. Romidepsin Product Portfolio
- 8.10.5 Cckinase, Inc. Recent Developments
- 8.11 Cayman Chemical Company
- 8.11.1 Cayman Chemical Company Company Information
- 8.11.2 Cayman Chemical Company Business Overview
- 8.11.3 Cayman Chemical Company Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Cayman Chemical Company Romidepsin Product Portfolio
- 8.11.5 Cayman Chemical Company Recent Developments
- 8.12 BPS Bioscience, Inc.
- 8.12.1 BPS Bioscience, Inc. Company Information
- 8.12.2 BPS Bioscience, Inc. Business Overview
- 8.12.3 BPS Bioscience, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 BPS Bioscience, Inc. Romidepsin Product Portfolio
- 8.12.5 BPS Bioscience, Inc. Recent Developments
- 8.13 Apexbio Technology LLC
- 8.13.1 Apexbio Technology LLC Company Information
- 8.13.2 Apexbio Technology LLC Business Overview
- 8.13.3 Apexbio Technology LLC Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Apexbio Technology LLC Romidepsin Product Portfolio
- 8.13.5 Apexbio Technology LLC Recent Developments
- 8.14 AdooQ BioScience
- 8.14.1 AdooQ BioScience Company Information
- 8.14.2 AdooQ BioScience Business Overview
- 8.14.3 AdooQ BioScience Romidepsin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 AdooQ BioScience Romidepsin Product Portfolio
- 8.14.5 AdooQ BioScience Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Romidepsin Value Chain Analysis
- 9.1.1 Romidepsin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Romidepsin Production Mode & Process
- 9.2 Romidepsin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Romidepsin Distributors
- 9.2.3 Romidepsin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst